More than six million Americans are blind from diseases that we still can’t cure, and that number is projected to reach nine million by 2020. The Moran Eye Center supports sixteen full research labs, advancing the understanding and treatment of diseases like glaucoma, macular degeneration, Stargardt, optic neuritis, and retinopathy of prematurity. “Hope without a plan is like a car without gas,” says Randall J Olson, MD, chair of the Department of Ophthalmology and CEO of the John A. Moran Eye Center, “and that gas is our research. Nothing else can replace it.”

Support Our Research

Center for Translational Medicine


Dr. Olson has spent years assembling top minds in ophthalmology and creating a uniquely creative and collaborative environment. In 2010 he and Gregory Hageman, PhD, launched the Center for Translational Medicine (CTM) to advance their most promising research into patient treatments. And in the past months, teams have made phenomenal breakthroughs in age-related macular degeneration (AMD) and glaucoma. And in December 2013, a major pharmaceutical company partnered with Hageman's team in an exclusive research collaboration to turn that science into new medicine.

Support the Center for Translational Medicine

International and Local Outreach

Woman having eyes examined

Eighty percent of blind individuals in the developing world could easily be cured by any modern ophthalmologist, but there just aren’t enough doctors to reach everyone who needs care. The John A. Moran Eye Center’s international outreach work addresses this shortage in a sustainable way, by training more eye doctors, nurses, and technicians in the places where they are most needed, and working with local partners to support them. Locally, Moran medical teams volunteer their time to provide care and surgery to those unable to pay, from Homeless Clinics in Salt Lake City to the Utah strip of the Navajo Nation.

Support International Outreach

Support Local Outreach